CD274 and ovarian carcinoma: The enhanced cytotoxic activity was supported by the slight expression of PD-L1 on ovarian cancer cells (3) suggesting that a certain Vδ1 T cell-subset could be suitable for a Vδ1 T-cell based immunotherapy.